← Insider buys
GLUE

Monte Rosa Therapeutics, Inc. · Healthcare

Chief Medical Officer Filip Janku sold $132K of Monte Rosa Therapeutics, Inc.

Sold$132,472
$24.50Price
5,407Shares
−8%Stake

What GLUE did after the filing

Filed Jul 1Copier in Jul 2
The stock from Thu, Jul 2 open, $23.56
−34.2%
S&P 500, same days
+3.9%

Measured over 30 trading days, to the Aug 14 close.

Traded Tue, Jun 30. Filed Wed, Jul 1, 4:57 PM ET, after the close. Returns use the Jul 2 open and the Aug 14 close. Not investment advice.